Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Vis

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Urologic Oncology|January 1, 2023
A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and <sup>18</sup>F-PSMA-PET/CTY J L Bodar, W I Luining, B Keizer, et al.
European Urology Oncology|December 19, 2025
Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computed TomographyK C C de Bie, M F Creanza, Y J L Bodar, et al.
The American Journal of Pathology|February 13, 2001
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic featuresJ C Alers, P J Krijtenburg, A N Vis, et al.
BMC Cancer|October 30, 2021
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trialF J Hinsenveld, B J Noordman, J L Boormans, et al.
Journal of Robotic Surgery|January 6, 2019
Linking surgical skills to postoperative outcomes: a Delphi study on the robot-assisted radical prostatectomyA J W Beulens, W M Brinkman, H G Van der Poel, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancerL G Zuur, A Jansen, S H van der Graaf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2019
Early lesion detection with <sup>18</sup>F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancerM Wondergem, B H E Jansen, F M van der Zant, et al.
World Journal of Urology|October 20, 2020
Detection of prostate cancer with <sup>18</sup>F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trialY J L Bodar, B H E Jansen, J P van der Voorn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2020
Pelvic lymph-node staging with <sup>18</sup>F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trialB H E Jansen, Y J L Bodar, G J C Zwezerijnen, et al.
Technology in Cancer Research & Treatment|January 29, 2016
Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate CancerB G Muller, A Swaan, D M de Bruin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Urologic Oncology|January 1, 2023
A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and <sup>18</sup>F-PSMA-PET/CTY J L Bodar, W I Luining, B Keizer, et al.
European Urology Oncology|December 19, 2025
Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computed TomographyK C C de Bie, M F Creanza, Y J L Bodar, et al.
The American Journal of Pathology|February 13, 2001
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic featuresJ C Alers, P J Krijtenburg, A N Vis, et al.
BMC Cancer|October 30, 2021
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trialF J Hinsenveld, B J Noordman, J L Boormans, et al.
Journal of Robotic Surgery|January 6, 2019
Linking surgical skills to postoperative outcomes: a Delphi study on the robot-assisted radical prostatectomyA J W Beulens, W M Brinkman, H G Van der Poel, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancerL G Zuur, A Jansen, S H van der Graaf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2019
Early lesion detection with <sup>18</sup>F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancerM Wondergem, B H E Jansen, F M van der Zant, et al.
World Journal of Urology|October 20, 2020
Detection of prostate cancer with <sup>18</sup>F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trialY J L Bodar, B H E Jansen, J P van der Voorn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2020
Pelvic lymph-node staging with <sup>18</sup>F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trialB H E Jansen, Y J L Bodar, G J C Zwezerijnen, et al.
Technology in Cancer Research & Treatment|January 29, 2016
Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate CancerB G Muller, A Swaan, D M de Bruin, et al.
Pageof 4